BTG Pactual Global Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BTG Pactual Global Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,263	Closed	-$598K	–	251
2015 Q1	$598K	Buy	6,263 +600	+11%	+$44.9K	0.05%	135
2014 Q4	$381K	Buy	5,663 +500	+10%	+$31K	0.03%	132
2014 Q3	$279K	Buy	+5,163	New	+$254K	0.03%	179

Other funds holding CBPO

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BTG Pactual Global Asset Management's CBPO Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2015, closing a stake of 6,263 shares — an estimated $598K sold.

BTG Pactual Global Asset Management first reported a position in CBPO in Q3 2014 and held it in 3 quarters. The position peaked at $598K in Q1 2015. 109 funds tracked by Wall St. Rank hold CBPO as of Q2 2015.

BTG Pactual Global Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 6,263 China Biologic Products Holdings, Inc. shares in Q2 2015, an estimated $598K.
BTG Pactual Global Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 3 quarters.
BTG Pactual Global Asset Management's China Biologic Products Holdings, Inc. position peaked at $598K in Q1 2015.
109 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.